The Board of Alltracel Pharmaceuticals Plc., (“Alltracel”, or “the Company”), (AIM:AP.L), the Medical Technology Company focused on the Woundcare, Oralcare and Cardiovascular Health markets today announces the resignation of Mr. Dennis Malamatinas from its Board. Concurrently, the Board is delighted to announce the appointment of Dr. Pat Fottrell as a non-executive director. Both announcements are made with immediate effect.
